Consistent with our results, through co-inhibition of SREBP-1 and FASN expression as well as reduction of lipogenesis, DFE suppressed growth and decreased migration and invasion in PCa cells (Figure 1 and Figure 2). The gene discussed is SREBF1; the disease is posterior cortical atrophy.